SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-057393
Filing Date
2012-08-13
Accepted
2012-08-13 16:52:01
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-17211_110q.htm 10-Q 761803
2 EX-31.1 a12-17211_1ex31d1.htm EX-31.1 10600
3 EX-31.2 a12-17211_1ex31d2.htm EX-31.2 10614
4 EX-32.1 a12-17211_1ex32d1.htm EX-32.1 7348
5 EX-32.2 a12-17211_1ex32d2.htm EX-32.2 7505
  Complete submission text file 0001104659-12-057393.txt   4741850

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20120630.xml EX-101.INS 619754
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20120630.xsd EX-101.SCH 25969
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20120630_cal.xml EX-101.CAL 59302
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20120630_def.xml EX-101.DEF 180850
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20120630_lab.xml EX-101.LAB 532996
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20120630_pre.xml EX-101.PRE 255456
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 121028222
SIC: 2834 Pharmaceutical Preparations